Creative Touch Permanent Makeup and Aesthetics

Catecholamines are a class of monoamine compounds, synthesised through the sequential enzymatic conversion of tyrosine → L-DOPA → dopamine → noradrenaline → adrenaline, with the final step (noradrenaline → adrenaline, catalysed by phenylethanolamine N-methyltransferase) occurring primarily in the adrenal medulla. Noradrenaline is additionally released directly from sympathetic nerve terminals throughout the body – including the perivascular and perifollicular dermis – making it both a circulating hormone and a local tissue neurotransmitter in skin. Adrenaline functions predominantly as a systemic circulating hormone from adrenal release. Dopamine’s skin-relevant actions are less well-characterised but include modulation of melanocyte function via D1/D2 receptor expression.

Catecholamines signal through adrenergic receptors – α1, α2, β1, β2, β3 subtypes – expressed on keratinocytes, fibroblasts, melanocytes, sebocytes, endothelial cells, and immune cells in skin. The receptor subtype distribution determines the tissue response: α-adrenergic receptor activation produces vasoconstriction; β-adrenergic activation modulates keratinocyte proliferation, sebaceous activity, and immune cell trafficking.

Skin-Relevant Actions

Vasoconstriction and tissue oxygenation: Noradrenaline acting on α1-adrenergic receptors on dermal arterioles produces vasoconstriction, reducing blood flow to the skin. Under acute stress this is adaptive – redirecting blood to skeletal muscle and vital organs. Under chronic stress the sustained reduction in dermal perfusion reduces oxygen and nutrient delivery to fibroblasts and keratinocytes, impairing collagen synthesis capacity, slowing cellular repair, and reducing the metabolic substrate available for barrier lipid production. The clinical correlate is the pale, dull complexion associated with chronic stress – a direct vascular consequence rather than a purely cosmetic observation.

Reactive oxygen species generation: Catecholamine metabolism – both enzymatic degradation by monoamine oxidase (MAO) and non-enzymatic auto-oxidation – generates hydrogen peroxide and superoxide as byproducts. Under chronic stress, the sustained catecholamine load produces a chronic low-grade ROS burden that, combined with the cortisol-driven antioxidant depletion described in the Psychological Stress entity, progressively exceeds the skin’s neutralisation capacity. The downstream consequences – AP-1 activation, MMP-1/ MMP-3 upregulation, collagen degradation, and DNA damage accumulation – are shared with the UV-driven photoageing pathway, suggesting that chronic psychological stress and chronic UV exposure converge on the same ECM degradation mechanism through different upstream routes.

Sebaceous stimulation: β-adrenergic receptor activation on sebocytes increases sebaceous lipid synthesis, contributing to the increased sebum output documented in psychological stress. This operates in parallel with the CRH-R1/sebocyte pathway ( CRH directly stimulating sebocyte lipid synthesis) and the ACTH-driven adrenal androgen pathway – three converging mechanisms by which stress increases sebum production, each potentially sufficient to exacerbate acne independently.

Immune modulation: β2-adrenergic receptor activation on T-lymphocytes and natural killer cells suppresses cytotoxic immune activity, contributing to the stress-related impairment of cutaneous immune surveillance. α-adrenergic stimulation of mast cells can trigger degranulation, contributing to neurogenic inflammation – particularly relevant in rosacea, where mast cell activation is a primary driver of the inflammatory vascular response, and in atopic dermatitis, where mast cell degranulation amplifies itch.